[1] 向越,付晓星.真武汤合血府逐瘀汤对慢性心衰患者心功能及心室重构的影响[J].医学临床研究, 2022, 39(9):1303-1306. [2] HEINZEL F R,HEGEMANN N,HOHENDANNER F,et al.Left ventricular dysfunction in heart failure with preserved ejection fraction molecular mechanisms and impact on right ventricular function[J].Cardiovasc Diagn Ther,2020, 10(5):1541-1560. [3] 李江,曹佳宁,刘文娴,等.沙库巴曲缬沙坦治疗老年人扩张型心肌病致慢性心力衰竭的疗效观察[J].中华老年医学杂志,2019,38(5):520-524. [4] 何雅,刘粉虾.动态心电图MTWA在慢性心力衰竭患者MACE预测中的应用价值[J].医学临床研究, 2023, 40(11):1638-1641. [5] 董萌. 沙库巴曲缬沙坦钠治疗老年慢性心力衰竭合并肾功能不全患者的临床观察[J].中国中西医结合急救杂志, 2020, 27(1):84-87. [6] 黄一伟,王军, 陈善浆. 恩格列净与西格列汀对 2 型糖尿病合并心力衰竭患者的心血管保护作用研究[J].全科医学临床与教育, 2023, 21(9):794-796. [7] 中华医学会心血管病学分会,中国医师协会心血管内科医师分会,中国医师协会心力衰竭专业委员会,等. 中国心力衰竭诊断和治疗指南2024[J].中华心血管病杂志,2024,52(3):235-275. [8] CAVUSOGLU Y, KAYA H, ERASLAN S,et al. Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction[J]. Hellenic J Cardiol,2019, 60(2):117-121. [9] MORROW D A, VELAZQUEZ E J, DEVORE A D,et al. Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF Trial [J]. Circulation,2019, 139(19):2285. [10] MORROW D A, VELAZQUEZ E J, DEVORE A D, et al. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial [J].Eur Heart J,2019, 40(40):3345-3352. [11] BUDNEVSKY A V, SHURUPOVA A D, KRAVCHENKO A Y, et al. Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure[J].Ter Arkh,2019, 91(3):36-41. [12] BASILE C,PAOLILLO S,GARGIULO P. Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis[J].J Cardiovasc Med (Hagerstown),2023,24(1):47. [13] CHIN K M, RUBIN L J, CHANNICK R, et al. Association of N-terminal pro brain natriuretic peptide and long-term outcome in patients with pulmonary arterial hypertension[J].Circulation,2019, 139(21):2440-2450. [14] 廖斌, 刘慧霞, 周洪,等. 西格列汀对老年2型糖尿病合并轻中度慢性心衰患者hs-CRP及NT-proBNP的影响[J].现代生物医学进展, 2019,7(26): 5059-5062.
2025, Vol. 42 
